| Product NDC: | 0074-3072 |
| Proprietary Name: | Advicor |
| Non Proprietary Name: | niacin and lovastatin |
| Active Ingredient(s): | 20; 750 mg/1; mg/1 & nbsp; niacin and lovastatin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0074-3072 |
| Labeler Name: | Abbott Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021249 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20011217 |
| Package NDC: | 0074-3072-90 |
| Package Description: | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-3072-90) |
| NDC Code | 0074-3072-90 |
| Proprietary Name | Advicor |
| Package Description | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-3072-90) |
| Product NDC | 0074-3072 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | niacin and lovastatin |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20011217 |
| Marketing Category Name | NDA |
| Labeler Name | Abbott Laboratories |
| Substance Name | LOVASTATIN; NIACIN |
| Strength Number | 20; 750 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Nicotinic Acid [EPC],Nicotinic Acids [Chemical/Ingredient],HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |